QT Ultrasound Partners with Shanghai-Based TCL Healthcare Equipment

September 10, 2020

QT Ultrasound, developer of the QTscan®, will bring its radiation- and compression-free 3D breast imaging technology to China, and other Asian markets, through a partnership with TCL Healthcare Equipment. The Shanghai-based company focuses on medical imaging equipment with proven expertise in bringing innovative products to Asia.

QT Ultrasound focused on China for international expansion because China is the second-largest medical device market in the world, following the United States. The market will continue to grow because the Chinese government is focused on improving healthcare access and outcomes by embracing technological innovation. The QTscan is particularly advantageous for Asian women because of its ability to accurately image dense breasts; an estimated 70% of Asian women have dense breasts, for which mammography has proven to be less sensitive in identifying masses. Both companies believe China is a country where the QTscan can have a very positive impact on women’s healthcare.

“QT Ultrasound is excited to partner with TCL Healthcare to bring our safe, innovative breast imaging technology to China. This team has the knowledge, experience, and relationships to take the QT Ultrasound Breast Scanner from approval through commercialization. We could not have found better partners,” says QT Ultrasound’s CEO and Founder, Dr. John Klock.

Mr. George Chan, Chairman of TCL Healthcare, understands that for health care to help save more lives, it needs to be affordable, which became the company’s mission. Mr. Chan says, “The QT Ultrasound Breast Scanner is exactly the right technology at the right time and will further our goal of screening for common cancers, especially screening for women – quickly, safely, and affordably.”

QT Ultrasound and TCL Healthcare share ambitious goals for providing women across Asia access to the QTscan. They expect to quickly commercialize the QTscan in China’s healthcare institutions and become a leader in the rapidly growing, breast imaging arena.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version